Search

Search Results

• Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review

  F. Capsoni

  6-13

  Published:

  1345

  PDF: 821
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  Published: 19 April 2021

  3476

  PDF: 487
• 

  A new MEFV gene mutation in an Iranian patient with familial Mediterranean fever

  S. Farjadian, F. Bonatti, A. Soriano, M. Reina, A. Adorni, C. Graziano, M. Moghtaderi, A. Percesepe, G. Romeo, D. Martorana

  85-87

  09-07-2019

  Published: 9 July 2019

  1027

  PDF: 763

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  Published:

  1988

  PDF: 1035

• Italian rheumatology for the Bone and Joint Decade 2000-2010; balance of the first two years and future prospects

  B. Canesi, A. Ciocci, V. Modena, M.A. Cimmino, R. Marcolongo

  214-216

  Published:

  1059

  PDF: 558
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  Published: 10 April 2020

  1251

  PDF: 662

• Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

  C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

  32-37

  Published:

  1550

  PDF: 707

• How to prescribe physical exercise in rheumatology

  S. Maddali Bongi, A. Del Rosso

  4-11

  Published:

  4024

  PDF: 2909

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  Published:

  1202

  PDF: 1868

• CLINICAL OUTCOME MEASURES OF PSORIASIS

  C. Bonifati, E. Berardesca

  64-67

  Published:

  948

  PDF: 2990

• Computerized acquisition and elaboration of clinical data in rheumatology during ten years: state of art and prospectives

  W. Troise Rioda, A. Nervetti

  131-139

  Published:

  700

  PDF: 635